{
    "Trade/Device Name(s)": [
        "ADVIA Chemistry CardioPhase High Sensitivity C-Reactive Protein (hsCRP) Assay",
        "ADVIA Chemistry CardioPhase High Sensitivity C-Reactive Protein Calibrators"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K081294",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033908",
        "K022682"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQD",
        "JIX"
    ],
    "Summary Letter Date": "July 29, 2008",
    "Summary Letter Received Date": "May 7, 2008",
    "Submission Date": "May 5, 2008",
    "Regulation Number(s)": [
        "21CFR866.5270"
    ],
    "Regulation Name(s)": [
        "C-Reactive Protein Immunological Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "C-Reactive Protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "Potassium EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Chemistry systems"
    ],
    "Method(s)/Technology(ies)": [
        "Latex-enhanced immuno-turbidimetric assay"
    ],
    "Methodologies": [
        "Quantitative protein determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Chemistry CardioPhase High Sensitivity C-Reactive Protein assay and calibrators for quantitative CRP measurement on ADVIA Chemistry systems.",
    "Indications for Use Summary": "For in vitro diagnostic quantitative determination of C-Reactive Protein (CRP) in human serum and plasma for infection, tissue injury, inflammation evaluation, and as an independent risk marker for future cardiovascular disease; calibrators are for ADVIA Chemistry system calibration for this method.",
    "fda_folder": "Immunology"
}